Nitric oxide, platelet function, myocardial infarction and reperfusion therapies

被引:40
作者
Alonso, D [1 ]
Radomski, MW [1 ]
机构
[1] Univ Texas, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA
基金
加拿大健康研究院;
关键词
nitric oxide; platelet function; myocardial infarction; reperfusion;
D O I
10.1023/A:1022194921040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets play an important role in physiologic hemostasis and pathologic thrombosis that complicate the course of vascular disorders. A number of platelet functions including adhesion, aggregation and recruitment are controlled by nitric oxide (NO) generated by platelets and the endothelial cells. Derangements in this generation may contribute to the pathogenesis of thrombotic complications of vascular disorders. The pharmacologic supplementation of the diseased vasculature with drugs releasing NO may help to restore the hemostatic balance.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 97 条
  • [41] Platelet reactivity in acute coronary syndromes: Evidence for differences in platelet behaviour between unstable angina and myocardial infarction
    Mathur, A
    Robinson, MSC
    Cotton, J
    Martin, JF
    Erusalimsky, JD
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 85 (06) : 989 - 994
  • [42] Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by S-nitrosoglutathione
    Mayers, I
    Salas, E
    Hurst, T
    Johnson, D
    Radomski, MW
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (05) : 1009 - 1016
  • [43] ASPIRIN IN MYOCARDIAL ISCHEMIA - WHY, WHEN, AND HOW MUCH - REVIEW
    MEHTA, JL
    CONTI, CR
    [J]. CLINICAL CARDIOLOGY, 1989, 12 (04) : 179 - 184
  • [44] NO-aspirins: Antithrombotic activity of derivatives of acetyl salicylic acid releasing nitric oxide
    Minuz, P
    Lechi, C
    Zuliani, V
    Gaino, S
    Tommasoli, R
    Lechi, A
    [J]. CARDIOVASCULAR DRUG REVIEWS, 1998, 16 (01): : 31 - 47
  • [45] ENDOGENOUS NITRIC-OXIDE - PHYSIOLOGY, PATHOLOGY AND CLINICAL RELEVANCE
    MONCADA, S
    HIGGS, EA
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (04) : 361 - 374
  • [46] MECHANISM OF ACTION OF SOME INHIBITORS OF ENDOTHELIUM-DERIVED RELAXING FACTOR
    MONCADA, S
    PALMER, RMJ
    GRYGLEWSKI, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (23) : 9164 - 9168
  • [47] ENDOTHELIUM-DERIVED RELAXING FACTOR - IDENTIFICATION AS NITRIC-OXIDE AND ROLE IN THE CONTROL OF VASCULAR TONE AND PLATELET-FUNCTION
    MONCADA, S
    RADOMSKI, MW
    PALMER, RMJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (13) : 2495 - 2501
  • [48] MONCADA S, 1991, PHARMACOL REV, V43, P109
  • [49] THE FORMATION OF NITRIC-OXIDE DONORS FROM PEROXYNITRITE
    MORO, MA
    DARLEYUSMAR, VM
    LIZASOAIN, I
    SU, YC
    KNOWLES, RG
    RADOMSKI, MW
    MONCADA, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (03) : 1999 - 2004
  • [50] PARADOXICAL FATE AND BIOLOGICAL ACTION OF PEROXYNITRITE ON HUMAN PLATELETS
    MORO, MA
    DARLEYUSMAR, VM
    GOODWIN, DA
    READ, NG
    ZAMORAPINO, R
    FEELISCH, M
    RADOMSKI, MW
    MONCADA, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) : 6702 - 6706